Spots Global Cancer Trial Database for colon adenocarcinoma
Every month we try and update this database with for colon adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | NCT00096278 | Colon Adenocarc... Stage IIA Colon... Stage IIB Colon... Stage IIC Colon... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... | Bevacizumab Fluorouracil Leucovorin Calc... Oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer | NCT04963283 | Colorectal Aden... Colon Cancer Colon Adenocarc... Rectum Cancer Rectal Cancer Rectal Adenocar... Colorectal Canc... | Cabozantinib Nivolumab | 18 Years - | University of Colorado, Denver | |
| The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery | NCT05872334 | Colon Cancer Rectal Cancer Colon Adenocarc... Rectal Adenocar... | Monofix | 18 Years - 80 Years | Samsung Medical Center | |
| Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy | NCT02569723 | Colon Adenocarc... | Carbon C 14 Oxa... Oxaliplatin | 18 Years - | University of California, Davis | |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery | NCT03365882 | Colon Adenocarc... ERBB2 Gene Ampl... Rectal Adenocar... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Rectal... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | Cetuximab Irinotecan Hydr... Laboratory Biom... Pertuzumab Trastuzumab HER-2 testing | 18 Years - | SWOG Cancer Research Network | |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer | NCT05710406 | Colon Adenocarc... Microsatellite ... Stage IIB Colon... Stage IIC Colon... Stage III Colon... | Encorafenib Cetuximab Biospecimen Col... Computed Tomogr... Magnetic Resona... Patient Observa... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer | NCT02368886 | Colon Adenocarc... Rectal Adenocar... Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Clobetasol Prop... Pharmacological... Quality-of-Life... Regorafenib | 18 Years - | Academic and Community Cancer Research United | |
| Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy | NCT06414304 | Colorectal Canc... Colorectal Canc... MSI-H Colorecta... dMMR Colorectal... Cancer Colon Adenocarc... | 18 Years - | OncoAtlas LLC | ||
| Audit of Surgery for Colorectal Cancer | NCT04349384 | Rectal Adenocar... Colon Adenocarc... | Colorectal rese... | 18 Years - | Institut National d'Oncologie, Morocco | |
| Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial | NCT04475159 | Metastatic Colo... Peritoneal Carc... Colon Adenocarc... | Pressurized Int... | 18 Years - | Sheba Medical Center | |
| Study of the Immune Response in Colon Adenocarcinoma | NCT03015038 | Colon Adenocarc... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Whole-Exome Sequencing (WES) of Cancer Patients | NCT02127359 | Lung Adenocarci... Colon Adenocarc... | 18 Years - | Dana-Farber Cancer Institute | ||
| Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study | NCT06017141 | Colon Adenocarc... | Biospecimen Col... Electronic Heal... Fentanyl Citrat... Propofol Questionnaire A... Sevoflurane Surgical Proced... | 18 Years - | University of Kansas Medical Center | |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer | NCT05710406 | Colon Adenocarc... Microsatellite ... Stage IIB Colon... Stage IIC Colon... Stage III Colon... | Encorafenib Cetuximab Biospecimen Col... Computed Tomogr... Magnetic Resona... Patient Observa... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Whole-Exome Sequencing (WES) of Cancer Patients | NCT02127359 | Lung Adenocarci... Colon Adenocarc... | 18 Years - | Dana-Farber Cancer Institute | ||
| Peptide-based Immunization for Colon- and and Pancreas-carcinoma | NCT03871790 | Colon Neoplasm Colon Adenocarc... Colon Cancer Colo-rectal Can... Rectal Cancer Rectal Neoplasm... Rectal Adenocar... Rectal Tumors Pancreatic Canc... Pancreas Cancer Pancreatic Neop... Pancreatic Aden... | 18 Years - | CENTOGENE GmbH Rostock | ||
| Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth | NCT04057274 | Colon Adenocarc... Colon Cancer | Exercise assess... | 50 Years - 90 Years | Northumbria University | |
| Young-Onset Colorectal Cancer | NCT02863107 | Colon Adenocarc... Colorectal Carc... Rectal Adenocar... | Biospecimen Col... Medical Chart R... Quality-of-Life... Questionnaire A... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer | NCT02575508 | Colon Adenocarc... Metastatic Panc... Pancreatic Aden... Pancreatic Duct... Rectal Adenocar... Stage III Pancr... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Pancre... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | Fluorouracil Irinotecan Hydr... Laboratory Biom... Oxaliplatin pan FGFR Kinase... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Validation of Aer-O-Scope Colonoscope System Cecal Intubation | NCT03949777 | Colonic Polyp Colonic Neoplas... Colonic Disease... Colon Adenoma Colon Disease Colon Adenocarc... Colon Cancer | Aer-O-Scope Col... | 45 Years - 75 Years | GI View Ltd. | |
| Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy | NCT02569723 | Colon Adenocarc... | Carbon C 14 Oxa... Oxaliplatin | 18 Years - | University of California, Davis | |
| Study of the Immune Response in Colon Adenocarcinoma | NCT03015038 | Colon Adenocarc... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer | NCT02368886 | Colon Adenocarc... Rectal Adenocar... Stage III Color... Stage IIIA Colo... Stage IIIB Colo... Stage IIIC Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Clobetasol Prop... Pharmacological... Quality-of-Life... Regorafenib | 18 Years - | Academic and Community Cancer Research United | |
| Oxaliplatin Microdosing Assay in Predicting Exposure and Sensitivity to Oxaliplatin-Based Chemotherapy | NCT02569723 | Colon Adenocarc... | Carbon C 14 Oxa... Oxaliplatin | 18 Years - | University of California, Davis | |
| Audit of Surgery for Colorectal Cancer | NCT04349384 | Rectal Adenocar... Colon Adenocarc... | Colorectal rese... | 18 Years - | Institut National d'Oncologie, Morocco | |
| Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial | NCT04475159 | Metastatic Colo... Peritoneal Carc... Colon Adenocarc... | Pressurized Int... | 18 Years - | Sheba Medical Center | |
| Study of the Immune Response in Colon Adenocarcinoma | NCT03015038 | Colon Adenocarc... | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | ||
| Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair | NCT02912559 | Colon Adenocarc... DNA Repair Diso... Lynch Syndrome Stage III Colon... | Atezolizumab Biospecimen Col... Computed Tomogr... Fluorouracil Leucovorin Calc... Magnetic Resona... Oxaliplatin Quality-of-Life... | 12 Years - | National Cancer Institute (NCI) | |
| Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | NCT04068103 | Colon Adenocarc... Stage IIA Colon... | Capecitabine Fluorouracil Leucovorin Leucovorin Calc... Oxaliplatin Patient Observa... | 18 Years - | NRG Oncology | |
| PeLear CCC: Proyecto Latino Contra Cancer Colorectal | NCT06426927 | Colorectal Canc... Rectal Cancer Colon Cancer Colon Rectal Ca... Rectal Neoplasm... Colon Adenocarc... Hereditary Nonp... | Colorectal Canc... | 18 Years - | University of North Carolina, Chapel Hill | |
| Role of Immunoscore® in Stage II-III Colorectal Cancer | NCT05422547 | Colon Adenocarc... | Immunoscore Col... | - | D'Or Institute for Research and Education | |
| Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | NCT04068103 | Colon Adenocarc... Stage IIA Colon... | Capecitabine Fluorouracil Leucovorin Leucovorin Calc... Oxaliplatin Patient Observa... | 18 Years - | NRG Oncology | |
| Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection | NCT06216405 | Colon Cancer Colon Polyp Colon Lesion Colon Adenocarc... | Colonoscopy | 18 Years - | Groupe Hospitalier Diaconesses Croix Saint-Simon | |
| Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer | NCT03936530 | Colorectal Neop... | 18 Years - 75 Years | Shanghai Minimally Invasive Surgery Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
